Zimmer Biomet Holdings ROE 2006-2018 | ZBH

Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.003B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $119.342B 18.47
Abbott Laboratories (ABT) United States $110.100B 24.06
Stryker (SYK) United States $65.814B 26.32
Boston Scientific (BSX) United States $46.845B 26.11
Baxter (BAX) United States $40.028B 28.64
ResMed (RMD) United States $15.613B 32.65
Smith & Nephew SNATS (SNN) United Kingdom $15.557B 0.00
Perrigo (PRGO) Ireland $10.804B 15.15
Bio-Rad Laboratories (BIO) United States $9.019B 72.75
Hill-Rom Holdings (HRC) United States $6.245B 22.44
ICU Medical (ICUI) United States $6.025B 56.06
Canopy Growth (CGC) Canada $5.716B 0.00
Agios Pharmaceuticals (AGIO) United States $5.207B 0.00
Insulet (PODD) United States $5.132B 0.00
Haemonetics (HAE) United States $5.062B 52.13
Neogen (NEOG) United States $4.333B 69.28
Hutchison China MediTech (HCM) China $4.232B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.064B 0.00
National Vision Holdings (EYE) United States $3.032B 0.00
NuVasive (NUVA) United States $2.737B 27.66
Quidel (QDEL) United States $2.658B 116.31
Phibro Animal Health (PAHC) United States $1.942B 28.83
Abaxis,Inc (ABAX) United States $1.906B 64.11
NxStage Medical (NXTM) United States $1.865B 0.00
VAREX IMAGING (VREX) United States $1.414B 21.78
Eagle Pharmaceuticals (EGRX) United States $1.216B 34.02
Cardiovascular Systems (CSII) United States $1.173B 0.00
Orthofix (OFIX) $1.089B 33.18
Owens & Minor (OMI) United States $1.074B 10.80
AtriCure (ATRC) United States $1.026B 0.00
OraSure Technologies (OSUR) United States $1.020B 61.89
Cerus (CERS) United States $0.967B 0.00
Omeros (OMER) United States $0.954B 0.00
TG Therapeutics (TGTX) United States $0.936B 0.00
MacroGenics (MGNX) United States $0.915B 0.00
Surmodics (SRDX) United States $0.784B 134.32
LeMaitre Vascular (LMAT) United States $0.709B 41.69
Meridian Bioscience (VIVO) United States $0.669B 23.58
PetIQ (PETQ) United States $0.639B 0.00
Insys Therapeutics (INSY) United States $0.571B 0.00
Lantheus Holdings (LNTH) United States $0.536B 14.00
Evolus (EOLS) United States $0.528B 0.00
Surface Oncology (SURF) United States $0.416B 0.00
Utah Medical Products (UTMD) United States $0.364B 24.11
Cytosorbents (CTSO) United States $0.362B 0.00
NanoString Technologies (NSTG) United States $0.328B 0.00
Quanterix (QTRX) United States $0.326B 0.00
BioLife Solutions (BLFS) United States $0.289B 0.00
Chimerix (CMRX) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.223B 0.00
Fonar (FONR) United States $0.173B 10.48
Bovie Medical (BVX) United States $0.168B 0.00
Chembio Diagnostics (CEMI) United States $0.158B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.136B 0.00
Female Health (VERU) United States $0.115B 0.00
Trinity Biotech (TRIB) Ireland $0.104B 31.00
Oramed Pharmaceuticals (ORMP) Israel $0.099B 0.00
United-Guardian (UG) United States $0.089B 20.91
Neurotrope (NTRP) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.074B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.047B 0.00
Capricor Therapeutics (CAPR) United States $0.041B 0.00
Valeritas Holdings (VLRX) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Akers Biosciences Inc (AKER) United States $0.034B 0.00
Myomo (MYO) United States $0.028B 0.00
Senestech (SNES) United States $0.026B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.003B 0.00